Related Experiment Video

Updated: Jun 21, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

ERBB2 suppression decreases cell growth via apoptosis in gastrointestinal adenocarcinomas

Amanda K Arrington1, Peter S Dahlberg, Julia Davydova

  • 1Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA.

Surgery
|July 25, 2009
PubMed
Abstract

Insights

Targeting ERBB2 in gastrointestinal adenocarcinomas with ERBB2 amplification may improve outcomes. Knocking down ERBB2 using siRNA reduced cancer cell viability and promoted apoptosis in cell line studies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Upper gastrointestinal (GI) adenocarcinomas, including esophageal and gastroesophageal junction cancers, show increasing incidence.
  • ERBB2 amplification is present in many GI adenocarcinomas, similar to breast cancer where ERBB2-targeted therapies are effective.

Purpose of the Study:

  • To investigate the therapeutic potential of targeting ERBB2 in GI adenocarcinomas.
  • To evaluate the effects of ERBB2 knockdown on cancer cell viability, apoptosis, and cell cycle progression.

Main Methods:

  • Utilized siRNA to knockdown ERBB2 expression in GI adenocarcinoma cell lines (Seg-1, OE19, MKN45).
  • OE19 and MKN45 cell lines possess known ERBB2 amplification, while Seg-1 has baseline ERBB2 levels.
  • Cells were treated with ERBB2-specific siRNAs or control siRNA.

Main Results:

  • ERBB2 knockdown significantly reduced ERBB2 protein levels in esophageal and gastric cancer cell lines with ERBB2 amplification.
  • Knockdown of ERBB2 led to decreased cancer cell viability.
  • The reduction in cell viability was primarily mediated through apoptotic pathways.

Conclusions:

  • ERBB2-targeted therapy shows promise for a subset of patients with GI adenocarcinomas harboring ERBB2 amplification.
  • Further investigation into ERBB2-directed therapies could lead to improved treatment strategies for these cancers.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...